Effectiveness of a Digital Treatment for Adolescents with Chronic Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Pain
- Sponsor
- University Rovira i Virgili
- Enrollment
- 195
- Locations
- 1
- Primary Endpoint
- Pain intensity
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Currently, psychosocial treatments enjoy strong empirical support and are crucial to maintaining and improving the quality of life of adolescents suffering from chronic pain. However, the availability of these evidence-based interventions is insufficient to meet the high demand, especially outside of large cities. The aim of this project is to develop a digital treatment that helps improve the quality of life of adolescents with chronic pain and complementary websites for their parents and teachers.
Investigators
Jordi Miró
Professor
University Rovira i Virgili
Eligibility Criteria
Inclusion Criteria
- •12-18 years old,
- •Having a non-oncology secondary chronic pain problem,
- •Having internet access,
- •A parent willing to participate in the study,
- •Providing informed consent/assent.
Exclusion Criteria
- •Cognitive or language problems
Outcomes
Primary Outcomes
Pain intensity
Time Frame: baseline, 8 weeks, 3 months follow-up
Refers to the severity of pain an individual experiences, measured on a scale (0-10)
Pain interference
Time Frame: baseline, 8 weeks, 3 months follow-up
Refers to the extent to which pain affects an individual's daily life and functioning. Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference will be used (0-32; 0=no interference, 32=intense interference).
Global perception of change after treatment
Time Frame: 8 weeks, 3 months follow-up
refers to an individual's overall assessment of how their condition has improved or worsened following a treatment, measured on a scale (0-10).